IOBT icon

IO Biotech

20 hedge funds and large institutions have $92.6M invested in IO Biotech in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
20
Holders Change
+20
Holders Change %
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NHAS
1
Novo Holdings A/S
Denmark
$21M 3,277,932 +3,277,932 New
VC
2
Vivo Capital
California
$19.3M 3,015,545 +3,015,545 New
RCM
3
RA Capital Management
Massachusetts
$11.9M 1,857,755 +1,857,755 New
ACA
4
Avoro Capital Advisors
New York
$10.2M 2,055,883 +2,055,883 New
Capital World Investors
5
Capital World Investors
California
$8.11M 1,235,000 +1,235,000 New
PHS
6
PFM Health Sciences
California
$7.74M 1,362,144 +1,362,144 New
SB
7
Samsara BioCapital
California
$7.17M 1,120,437 +1,120,437 New
SCM
8
Soleus Capital Management
Connecticut
$4.31M 672,734 +672,734 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.31M 205,200 +205,200 New
Millennium Management
10
Millennium Management
New York
$512K 77,963 +77,963 New
CCM
11
CAAS Capital Management
New York
$323K 50,479 +50,479 New
Norges Bank
12
Norges Bank
Norway
$164K 25,000 +25,000 New
Squarepoint
13
Squarepoint
New York
$98K 14,966 +14,966 New
Citadel Advisors
14
Citadel Advisors
Florida
$86K 13,060 +13,060 New
VF
15
Virtu Financial
New York
$83K 12,665 +12,665 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$73K 11,173 +11,173 New
Stifel Financial
17
Stifel Financial
Missouri
$64K 10,000 +10,000 New
Bank of America
18
Bank of America
North Carolina
$64K 10,000 +10,000 New
Morgan Stanley
19
Morgan Stanley
New York
$57K 8,958 +8,958 New
TRCT
20
Tower Research Capital (TRC)
New York
$10K 1,572 +1,572 New
CFGS
21
Concourse Financial Group Securities
Alabama